Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Hospital Morvan

2 abstracts

Abstract
Real-world effectiveness and safety of amivantamab for exon 20 EGFR-mutant non-small cell lung cancer (NSCLC) in French early access program: Amexon 20 GFPC.
Org: Hospices Civils of Lyon, Hospital Morvan, Hospital Albert Calmette, CHU Saint-Denis La Réunion, Saint-Denis,
Abstract
Explore ALK: Alectinib activity in patients with ALK+ metastatic non-small cell lung cancer—A national real world analysis (GFPC 03-2019).
Org: Centre Léon Bérard, CHI Créteil, Rouen University Hospital, Hopital Foch, Nord University Hospital,